Back
Royal Caribbean Group Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
69
RCL
Royal Caribbean Group
Last Price:
140.60
Seasonality Move:
3.33%
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-20.46%
Buy
69
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $140.59. The Score for RCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $140.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing buying pressure, which is a positive indicator for future bullish movement.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $23.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 64.91 | Buy |
| Chaikin Money Flow: | 2364054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130 - 138.9) | Buy |
| Bollinger Bands (100): | (119.56 - 132.88) | Buy |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.44 | Sell |
| Relative Strength Index (14 RSI): | 34.11 | Sell |
| Chaikin Money Flow: | -30640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.57 - 31.31) | Sell |
| Bollinger Bands (100): | (18.43 - 29.93) | Sell |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.53 | Buy |
| 20-day SMA: | 133.67 | Buy |
| 50-day SMA: | 129.77 | Buy |
| 200-day SMA: | 111.54 | Buy |
| 8-day EMA: | 135.26 | Buy |
| 20-day EMA: | 133.47 | Buy |
| 50-day EMA: | 130.3 | Buy |
| 200-day EMA: | 112.73 | Buy |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.7 | Sell |
| 20-day SMA: | 26.48 | Sell |
| 50-day SMA: | 28.52 | Sell |
| 200-day SMA: | 19.19 | Buy |
| 8-day EMA: | 24.68 | Sell |
| 20-day EMA: | 26.35 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 21.52 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.30 per share, a decrease next quarter of $1.54 per share, an increase this year of $4.13 per share, and an increase next year of $1.54 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Royal Caribbean Group Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||